fotemustine has been researched along with Hepatocellular Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruckner, E; Kővári, B; Langner, C; Lauwers, GY; Varelas, AI | 1 |
1 other study(ies) available for fotemustine and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Metachronous double-hit by transarterial chemoembolisation (TACE) with fotemustine inducing dysplasia-like atypia in the gallbladder and stomach-A diagnostic pitfall.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Gallbladder; Humans; Liver Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Stomach; Treatment Outcome | 2022 |